Rahul Banerjee: My takeaways from RedirecTT-1 for Fred Hutchinson Cancer Center journal watch
Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared a post on X:
“My takeaways from RedirecTT-1 (tal/tec dual bsAbs in myeloma) for Fred Hutchinson Cancer Center journal watch.
Images but technically no memes in my talk.
Efficacy and safety profiles are both striking! I can’t help but wonder what earlier IVIG and bsAb de-escalation might have done.”
Rahul Banerjee is an assistant professor at Fred Hutchinson Cancer Center at the University of Washington. He completed his residency at the University of Pennsylvania health system.
He completed his fellowship in haematology and oncology from the University of California, San Francisco. He has authored over 70 peer-reviewed publications. His clinical interests include multiple myeloma.
More posts featuring Rahul Banerjee.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023